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ABSTRACT
Small supernumerary marker chromosomes (sSMCs) are defined as structurally abnormal chromosomes that cannot be identified or 
characterized by conventional karyotype analysis and are generally equal in size or smaller than chromosome 20. Here, we present the 
molecular characterization of an sSMCs derived from chromosome 15 in prenatal diagnosis in a 38-years-old female.
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Small supernumerary marker chromosomes (sSMCs) are defined as structurally abnormal chromosomes that cannot be identified or characterized by conventional 
karyotype analysis and are generally equal in size or smaller than 
chromosome 20 [1]. sSMCs are present in nearly 0.044% of live 
births and 0.075% of prenatal cases [2,3]. Approximately 77% of 
sSMCs arise de novo and 23% are inherited [2,3]. Nearly 70% 
of sSMCs are derived from the short arms and pericentromeric 
regions of acrocentric chromosomes [4]. 
Most (70%) of de novo sSMCs have no phenotypic 
effects [5]. However, in at least 30-50% of prenatally detected 
sSMCs cases, the pregnancy is terminated [2,3] which means 
unnecessary abortions were induced in a certain percentage of 
potentially healthy children with sSMCs. Therefore the precise 
characterization of marker chromosomes is crucial for prenatal 
diagnosis and proper genetic counseling. Here, we present 
the molecular characterization of an sSMCs derived from 
chromosome 15 in prenatal diagnosis.
CASE REPORT
A 38-years-old female, G3P1A1L1 presented at 17 weeks of 
gestation with a history of her girl child aged 6 years having Global 
development delay. Her period of gestation was corresponding to 
the Ultrasonography. She had undergone combined first-trimester 
screening by which was reported to be low risk. There was no 
gross congenital malformation in the fetus of present pregnancy.
She had delivered a girl child six years back at term by an 
Emergency Cesarean section for non-progress of labor. The child 
had delayed milestones and mild facial dysmorphism for which 
she was evaluated and diagnosed to have Global developmental 
delay. The genetic evaluation was done including Comparative 
Genomic Hybridization (CGH) array and Fluorescent in situ 
hybridization (FISH) which diagnosed the presence of a marker 
chromosome in the child, 47, XX + mar. On parental evaluation, 
the paternal karyotype was normal 46 XY and mother was detected 
to have the same marker chromosome. However, the mother was 
phenotypically and functionally normal and part of the medical 
profession. A 2.05 Mb duplication was detected on the long arm 
of chromosome 15 (cytogenetic location 15q11.1q11.2).
Since both the mother and the child had the identical marker 
chromosome and mother being normal, the Global development 
delay could not be completely attributed to the marker 
chromosome. The microarray report of both proband and the 
mother was awaited. Meanwhile, the parents opted for prenatal 
testing by amniocentesis and full Karyotype and FISH studies 
in the fetus of present pregnancy. She underwent an uneventful 
procedure and was discharged the same day. FISH was performed 
on the cells from the amniotic fluid sample using Vlysis DNA 
probe LSI SNRPN/LSIPML/CEP (tricolor). Signal enumeration 
Figure 1: Amniotic fluid Karyotype of fetus.
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was done in 50 cells. The final report of the amniotic fluid 
karyotype was the same as the mother and the index case (Fig. 1).
Post-counselling, the couple refused further analysis and 
opted for termination. The abortus underwent an autopsy wherein 
no structural abnormality was detected. The final microarray 
reports of the proband fetus and the mother were reported as 
follows: Fetus: Genomic duplication of 2.6 Mb on cytoband 
15q11.1q11.2 starting from 20.055, 137bp to 22,698,581 
bp on the long arm of Chromosome #15. This has been 
reported benign on ISCA Database (Fig. 2). Mother: Genomic 
duplication of 2.6Mb on cytoband 15q11.1q11.2 starting from 
20,095,481 to 22,698,581bp on long arm q of chromosome#15. 
This has been reported benign on ISCA Database (Fig. 3). Loss 
of heterozygosity (LOH) of 19.2Mb was seen on Chromosome 
#16. It may be due to parental consanguinity which was absent 
in this case and can lead to uniparental disomy. Proband: 
Genomic duplication of 2.6Mb on cytoband 15q11.1q11.2 
starting from 20.055,137 bp to 22,698,581 bp on the long arm 
of Chromosome#15. This has been reported benign by ISCA 
Database. Genomic duplication of 177 Kb on cytoband 9p 24.3 
starting from 204,193 bp to 381,489 was present on the short 
arm p of chromosome # 9. Reported uncertain likely benign by 
ISCA (Fig. 4).
DISCUSSION
It is estimated that 50% of all sSMCs are derived from 
chromosome 15 [6]. Children with an sSMCs are individually 
very different from each other, even when the sSMCs causes 
a known syndrome. Wong et al reported a de novo marker 
chromosome part of 15 detected on amniocentesis in a 21-year-
old woman with high risk for Trisomy 21 on combined screen. 
Parental Karyotype was normal and the fetus did not have any 
anomaly or dysmorphism on sonography. Pregnancy outcome 
was successful with the baby having karyotype 47XY+Marker. At 
one year of age, the baby was progressing normally [7]. Jon Soo 
Kim et al reported a 10-month-old female infant referred to their 
pediatric neurology clinic for uncontrolled seizures and global 
developmental delay. Array CGH showed amplification from 
15q11.1 to 15q13.1 spanning 8.47 Mb [6]. The reported clinical 
features of patients with 15q13.3 microdeletion and duplication 
are rather heterogeneous, ranging from mental retardation and 
psychiatric illness to seizures. In the present case, the proband 
and the mother had the same marker chromosome on routine 
karyotype and FISH; however, the mother was phenotypically 
and functionally normal. 
Approximately 70% of SMCs are de novo and 30% are 
inherited. The most common SMCs are derived from acrocentric 
chromosomes and have a satellited or bisatellited structure. 
Chromosome 15 accounts for the highest percentage (~50%) 
of this group. Melo et al [8] reported a case of a 39-year-old 
woman who underwent amniocentesis at 16 weeks of gestation 
for advanced maternal age. An abnormal fetal karyotype – 47, 
XX,+mar – with one sSMCs was detected in all metaphases. 
Cytogenetic and molecular analyses revealed a fetal karyotype 
47, XX,+mar patishidic (15)(ql2)(D15Zl++,SNRPN−), in which 
the sSMCs (15) was a paternally inherited inverted duplicated 
chromosome and did not contain the critical region of Prader–
Willi/Angelman syndromes. Uniparental disomy was excluded 
and genetic sonogram was normal, pregnancy outcome was a 
normal baby. 
This case supports the literature in two aspects: sSMCs 
(15) that do not contain PWACR generally have a normal 
phenotype, and sSMCs transmitted by normal carriers to their 
offspring are not commonly correlated with clinical problems 
[8]. Some sSMCs lead to specific syndromes. Entire and partial 
gene deletions/ duplications can produce a completely different 
phenotypic effect. The low copy repeats (LCRs) in chromosome 
15q11q13 have been recognized as Breakpoints (BP) for not 
only intra chromosomal deletions and duplications but also small 
supernumerary marker chromosomes 15, sSMCs (15) [9]. 
Most sSMCs (15) take the form of a dicentric inv dup and can 
be classified into two groups: small sSMCs (15) and large sSMCs 
(15). The small sSMCs (15) are metacentric chromosomes 
without euchromatic material and do not contain the Prader-Willi/
Angelman Critic Region (PWACR), which usually clinically 
irrelevant. In contrast, the large sSMCs (15) are acrocentric 
chromosomes containing copies of PWACR and are frequently 
associated with abnormal phenotype (mELO). For the other 
sSMCs, it is still not possible to predict outcomes, although 
Figure 3: Microarray of mother.Figure2: Amniotic fluid Microarray of Fetus.
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new cases can now be compared with the cases collected on the 
sSMCs website [9,10].
If a child has problems with growth or development, it is likely 
that the sSMCs has affected them but the cause could also be 
something different, not the sSMCs. The correct characterization 
of gene deletions and duplications is a crucial point in order to 
identify the genotype phenotype correlation.  Some conclusions 
can be drawn by comparing other cases from the medical literature. 
Conventional karyotype analysis can detect numerical and 
structural chromosomal abnormalities but cannot determine the 
origin and genetic content of sSMCs. Array CGH has the ability to 
detect DNA dosage imbalance including deletions and duplications 
in the euchromatic regions and is useful for the characterization of 
the origin and hereditary effects in the sSMCs [11].
Sun et al [12] reported the analysis of twenty cases with sSMCs 
initially were detected by G-binding karyotype. Routine cytogenetic 
analysis showed mosaic marker chromosome in six out of the 20 cases. 
All the 20 cases were subjected to a CGH assay, and seventeen of them 
were successfully identified for the chromosome origin. Array CGH 
has many advantages that make it extremely useful for characterizing 
sSMCs. It clearly and easily determines the components of sSMCs 
in a single assay. This advantage was especially useful for complex 
sSMCs and multiple sSMCs. Complex sSMCs is a subgroup of 
sSMCs which consist of chromosomal materials derived from more 
than one chromosome [12]. Vetro et al [13] reported 4 cases of sSMCs 
that after array CGH was interpreted rather differently reporting two 
types of complex markers which DNA content was overlooked by 
conventional approaches. All are likely derived from partial trisomy 
rescue events thus changing the present ideas on composition of 
supernumerary marker chromosome [13]. In the present case, the 
proband also had an additional genomic duplication in the short arm 
of chromosome #9. 
Glessner et al in the first meta-analysis of copy number 
variations (CNVs) studied five cohorts including Autism spectrum 
disorders (ASD) and Attention deficit hyperactivity disorders 
(ADHD). They stated that cumulative evidence indicates a shared 
genetic etiology of neurodevelopmental and neuropsychiatric 
diseases. They identified the DOCK8/KANK1 locus as containing 
exonic CNVs with genome-wide significant meta P values and 
consistent direction of effects across all five cohorts. There was 
a significant association of genomic duplication in Chromosome 
#9 short arm with ADS, ADHD and Neuropsychiatric illnesses 
[14]. In the present case, though the parents opted for termination 
based on the FISH report, the array CGH would have given 
the clarity towards whether the fetus would have been actually 
affected as its microarray did not show the genomic duplication in 
chromosome #9 present in the proband. The marker chromosome 
was only coincidental to the developmental delay. 
Presence of uniparental disomy as a cause for sSMCs is being 
investigated. In a review article Kotzot stated that the incidence 
of UPD in cases with sSMCs is increased by coincidence, 
ascertainment bias and because for most chromosomes only 
then is the fetus viable [15]. In this case study, we validate that 
array CGH analysis provides an alternative to telomere FISH and 
disease-specific FISH in the cytogenetic diagnostic laboratory. 
CONCLUSION 
We conclude that array CGH is a modern and precise diagnostic 
tool that will complement and enhance current methods of 
detecting chromosomal imbalances prenatally. In a combination 
of a detailed ultrasound examination and karyotype analysis, it 
can provide more precise and rapid prenatal diagnosis of sSMCs. 
It is suggested that UPD is always tested for when an sSMCs is 
detected. In order to establish a stronger base for clinical service 
in the future and avoid miss characterization, more sSMCs cases 
need to be detailed characterized. This will help to clarify the 
variable clinical characteristics of sSMCs and provide additional 
information to aid clinical service and future research.
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